Home/Filings/4/0000914190-09-000242
4//SEC Filing

Kallok Michael J 4

Accession 0000914190-09-000242

CIK 0001222929other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:22 PM ET

Size

20.7 KB

Accession

0000914190-09-000242

Insider Transaction Report

Form 4
Period: 2009-02-25
Kallok Michael J
DirectorChief Scientific Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-2520,0000 total
    Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-2550,0000 total
    Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-2525,0000 total
    Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-25100,0000 total
    Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-2550,0000 total
    Common Stock (50,000 underlying)
  • Disposition to Issuer

    Common Stock

    2009-02-255,5000 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-25488,2150 total
    Common Stock (488,215 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-02-2550,0000 total
    Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each share of the issuer's common stock was converted into 0.647 shares of common stock of Replidyne, Inc.
  • [F2]Disposed of pursuant to a merger agreement among issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each of the issuer's stock options was assumed by Replidyne, Inc. and became exercisable to purchase shares of Replidyne, Inc. common stock; each share covered by the issuer's options was converted into 0.647 shares of common stock of Replidyne, Inc., and the exercise price of each option was adjusted by dividing the pre-merger exercise price by 0.647 and rounding up to the nearest cent.

Issuer

CARDIOVASCULAR SYSTEMS INC

CIK 0001222929

Entity typeother

Related Parties

1
  • filerCIK 0001428091

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:22 PM ET
Size
20.7 KB